Large gap with delayed quotes
|
Last quote
08/30/2025
-
02:00:00
|
Bid
08/29/2025 -
21:59:58
|
Bid Volume |
Ask
08/29/2025 -
21:59:58
|
Ask Volume |
|---|---|---|---|---|
|
19.11
-0.20
(
-1.04% )
|
19.10
|
15,100 |
19.11
|
2,200 |
Analysis date: 29.08.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 19.08.2025.
Interest
Strong
Strong
Three stars since 19.08.2025.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 08.08.2025 at a price of 18.72.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 11.04.2025.
4wk Rel Perf
5.54%
5.54%
The four-week dividend-adjusted overperformance versus SP500 is 5.54%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 12.08.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.99%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.40%.
Mkt Cap in $bn
4.58
4.58
With a market capitalization between $2 & $8bn, SABRA HEALTHCARE REIT. is considered a mid-cap stock.
G/PE Ratio
0.93
0.93
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
23.22
23.22
The estimated PE is for the year 2027.
LT Growth
15.11%
15.11%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
6.38%
6.38%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
32
32
For 1% of index variation, the stock varies on average by 0.32%.
Correlation
0.28
0.28
Stock movements are strongly independent of index variations.
Value at Risk
1.69
1.69
The value at risk is estimated at USD 1.69. The risk is therefore 8.85%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
09.07.2008
09.07.2008